Health
ASCO Day 3: Cancer Advances and Setbacks
At the American Society of Clinical Oncology (ASCO) conference, pancreatic cancer treatment saw significant progress. However, Akeso and Summit faced setbacks in their respective trials.
Coverage timeline — 1 article
STAT News
ASCO Day 3: A huge advance for pancreatic cancer, a let down for Akeso and Summit, and a new approach to immunotherapy.
2026-05-31 23:03 UTC